Bio Marketing

Mallinckrodt's CELLEX® ECP System Reimbursed in Japan for cGvHD Treatment

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD &nd...

 March 09, 2023 | News

Abacus Medicine Pharma Services and AddMedica Sign Partnership Agreement for the Distribution of Siklos® in Benelux

Simon Estcourt, Managing Director of Abacus Medicine Pharma Services explains: “This partnership agreement between Abacus Medicine Pharma Servic...

 March 07, 2023 | News

Lexicon Reveals “INTO THE DARK” Awareness Campaign

Emphasizes challenges faced by patients and clinicians within the first 30 days after discharge from a heart failure hospitalization   Reinforces im...

 March 06, 2023 | News

Biogen Japan and Eisai Provide Update on Co-Promotion Of Multiple Sclerosis Treatments In Japan

The two companies have been jointly engaged in promotional activities for MS treatments in Japan. However, since a certain objective has been achieved rega...

 March 02, 2023 | News

Karyopharm and Menarini Group Receive Full Marketing Authorization

Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication – - Karyopharm Therapeutics Inc. (Nasda...

 February 22, 2023 | News

Dolomite Bio announces re brand to Do Bio

The expertise behind Do bio’s technology is built on a strong foundation in the field of microfluidics. As the company has grown in recent years, the...

 February 09, 2023 | News

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences...

 February 09, 2023 | News

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings Biosynex SA (“Biosynex”) (EPA: ALBIO), a French m...

 February 01, 2023 | News

Junshi Biosciences Announces Approval for Marketing of VV116 in China

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company ded...

 January 31, 2023 | News

Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Fos...

 January 16, 2023 | News

Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer's Disease in Japan

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Mass...

 January 16, 2023 | News

GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer (CSO)

With ambitious plans to expand the reach and impact of their Flash Oxidation (Fox™) Protein Footprinting System beyond in vitro proteins,&n...

 January 11, 2023 | News

CG Life and MC Services establish US-EU strategic partnership

-CG Life, an integrated digital marketing and PR agency supporting life sciences and healthcare companies, and MC Services AG, a major European P...

 January 09, 2023 | News

Polysciences Announces New Bioprocessing Brand, Kyfora Bio

Building on Polysciences’ extensive experience in developing and manufacturing monomers, polymers, microspheres, and specialty reagents for the medic...

 January 03, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close